Start:
February 2014
End:
November 2014
Enrollment:
52
This Phase IB/II clinical trial will test the safety and efficacy of the experimental drug ITI-007 in older adults with dementia and in cognitively normal volunteers age 65 and older.
Minimum Age: 65 Years
Maximum Age: N/A
Healthy Participants
Participants with Dementia
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: Intra-Cellular Therapies, Inc.
Source: ClinicalTrials.gov ID: NCT02078310
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health